In our pooled analysis, neutropenia was the most common Grade ≥ 3 AE; interestingly, incidence of neutropenia was not increased in patients >65 years, consistent with data reported from an FDA pooled analysis of CDK4 and 6 inhibitors in older women [5]. Here, CDK4 is linked to neutropenia.